Anti-Snoring Treatment Market: By Devices (Mandible Advancement Devices, Tongue Stabilizing Devices, Nasal Devices, Continuous Positive Airway Pressure Devices, Chin Straps), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, E-commerce) and Geography

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Anti-Snoring Treatment Market is estimated to be valued at USD 4,982.1 million in 2022 and is poised to grow at a significant CAGR of 8.9% over 2023-2029. Snoring is a hoarse sound generated when air rushes through relaxed tissues in the throat, causing friction between the tissues and causing vibrations during breathing. Snoring is a frequent occurrence in the population, but it can be a major health issue for some people. Snoring is commonly associated with a sleep problem known as obstructive sleep apnea (OSA) drugs. The mandible advancement devices segment is anticipated to grow at significant CAGR over the forecast years owing to increased demand mandibular advancement device (MAD) are most widely used mouth device for sleep apnea patients. Mandibular advancement device (MAD) resembles a mouth guard used in sports. Moreover, these devices snap over the upper and lower dental arches and have metal hinges that makes it possible for the lower jaw to move forward. Moreover, rising prevalence of sleep apnea and OSAHS, rise in the geriatric population leading to increasing sleep disorder, which is associated with age, and increasing applications of mandibular advancement devices for treatment of snoring and OSA over CPAP systems.

Anti-Snoring Treatment Market Key Developments:
In February 2021, the United States Food and Drug Administration (US FDA) approved the commercialization of a prescription-only anti-snoring device, ''eXciteOSA'', developed by Rotech Healthcare. It delivers electrical muscle stimulation via a mouthpiece that is placed around the tongue.

Anti-Snoring Treatment Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Anti-Snoring Treatment Market Dynamics

The rising prevalence of different sleep disorders will drive revenue growth in the global anti-snoring therapy market in the approaching years. According to the American Sleep Association, roughly 50-70 million persons in the United States have a sleep disturbance, with 48 percent reporting snoring. Snoring is believed to affect 40% of women and 57% of men in the United States. Obesity, alcohol intake, sedative prescription usage, chronic nasal congestion, and pregnancy are the key factors leading to the rising incidence of snoring. As a result, increased prevalence and awareness of snoring problems will drive market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Anti-Snoring Treatment Market Segmentation

By Devices
  • Mandible Advancement Devices
  • Tongue Stabilizing Devices
  • Nasal Devices
  • Continuous Positive Airways Pressure Devices
  • Chin Straps
  • Others
By Distribution Channel
  • Hospitals
  • Clinics
  • Retail Pharmacies
  • E-commerce
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

2022 is the base year and 2029 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  • Sleeping Well, LLC (U.S.)
  • Apnea Sciences Corporation (U.S.)
  • Tomed Dr. Toussaint GmbH (Germany)
  • Sleep Well Enjoy Life, Ltd. (U.K.)
  • MEDiTAS Ltd. (U.K.)
  • GSK plc. (U.K.)
  • HoMedics Group Canada Co (Canada)
  • Contour Products, Inc. (U.S.)
  • Theravent, Inc. (U.S.)
  • MPowRx Health & Wellness Products, Inc. (Canada),
  • Innovative Health Technologies (NZ) Ltd.